UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A national assessment of standards of care for inherited bleeding disorders in Canada

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-11, Vol.29 (6), p.1450-1455

2023

Volltextzugriff (PDF)

Ecological diversification in the Bacillus cereus Group

Environmental microbiology, 2008-04, Vol.10 (4), p.851-865

2008

Volltextzugriff (PDF)

Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis

CNS drugs, 2021-05, Vol.35 (5), p.469-481

2021

Volltextzugriff (PDF)

Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study

BMC cancer, 2021-11, Vol.21 (1), p.1207-1207, Article 1207

2021

Volltextzugriff (PDF)

Correction to: Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study

BMC cancer, 2021-12, Vol.21 (1), p.1-1291, Article 1291

2021

Volltextzugriff (PDF)

Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma initiating daratumumab: A real-world chart review study

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22 (8), p.e708-e715

2022

Volltextzugriff (PDF)

Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study

Clinical lymphoma, myeloma and leukemia, 2024-01, Vol.24 (1), p.55-63

2024

Volltextzugriff (PDF)

Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics

Journal of medical economics, 2018-02, Vol.21 (2), p.135-143

2018

Volltextzugriff (PDF)

Systematic review of risk and protective factors associated with substance use and abuse in individuals with autism spectrum disorders

Autism : the international journal of research and practice, 2020-05, Vol.24 (4), p.899-918

2020

Volltextzugriff (PDF)

Antimicrobial Resistance in the Environment: Towards Elucidating the Roles of Bioaerosols in Transmission and Detection of Antibacterial Resistance Genes

Antibiotics (Basel), 2022-07, Vol.11 (7), p.974

2022

Volltextzugriff (PDF)

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Lancet neurology, 2023-05, Vol.22 (5), p.383-394

2023

Volltextzugriff (PDF)

Real-world healthcare resource utilization and costs among patients with multiple myeloma in the United States

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18811-e18811

2022

Volltextzugriff (PDF)

Comparison of Time to Next Treatment or Death between Front-Line Daratumumab, Lenalidomide, and Dexamethasone (DRd) and Bortezomib, Lenalidomide, and Dexamethasone (VRd) in Transplant Ineligible Patients with Multiple Myeloma

Blood, 2023-11, Vol.142 (Supplement 1), p.543-543

2023

Volltextzugriff (PDF)

Ensuring a Successful Transition From Cytology to Human Papillomavirus-Based Primary Cervical Cancer Screening in Canada by Investigating the Psychosocial Correlates of Women's Intentions: Protocol for an Observational Study

JMIR research protocols, 2022-06, Vol.11 (6), p.e38917-e38917

2022

Volltextzugriff (PDF)

Patient Characteristics, Treatment Patterns and Outcomes Among Black and White Patients with Multiple Myeloma Initiating Daratumumab: A Real-World Chart Review Study

Blood, 2021-11, Vol.138 (Supplement 1), p.1965-1965

2021

Volltextzugriff (PDF)

Correction to: Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis

CNS drugs, 2021-08, Vol.35 (8), p.923-923

2021

Volltextzugriff (PDF)

Treatment response among patients with multiple myeloma initiating daratumumab across different lines of therapy: A real-world chart review study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18737-e18737

2021

Volltextzugriff (PDF)

Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: The HF-ACTION study

The American heart journal, 2009-10, Vol.158 (4), p.S45-S52

2009

Volltextzugriff (PDF)

POSTER: MM-493 Progression-Free Survival of Daratumumab vs Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients: TAURUS Chart Review Study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S221-S221

2023

Volltextzugriff (PDF)

MM-493 Progression-Free Survival of Daratumumab vs Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients: TAURUS Chart Review Study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S502-S502

2023

Volltextzugriff (PDF)

Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma mnitiating daratumumab: A real-world chart review study

Clinical lymphoma, myeloma and leukemia, 2022-03

2022

Volltextzugriff (PDF)

Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials

JAMA : the journal of the American Medical Association, 2023-11, Vol.330 (18), p.1745

2023

Volltextzugriff (PDF)

P-115 Progression-free survival of daratumumab vs. bortezomib triplet combination with lenalidomide and dexamethasone in transplant ineligible newly diagnosed multiple myeloma patients: a chart review study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S98-S98

2023

Volltextzugriff (PDF)

En temps de crise, prendre le temps

Développement durable & territoires, 2020-07

2020

Volltextzugriff (PDF)

Ecological diversification in the Bacillus cereus Group

Environmental microbiology, 2007, Vol.10 (4), p.1-15

2007

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Humans
(8)
Male
(5)
Middle Aged
(5)
Adult
(4)
Environmental Sciences
(4)
Female
(4)
Hematology
(3)
Life Sciences
(3)
Oncology
(3)
Patients
(3)
Progression-Free Survival
(3)
Systematic Review
(3)
Treatment Outcome
(3)
Adolescent
(2)
Aged
(2)
Antipsychotic Agents - Administration & Dosage
(2)
Antipsychotic Agents - Economics
(2)
Biochemistry, Molecular Biology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A national assessment of standards of care for inherited bleeding disorders in Canada

Ecological diversification in the Bacillus cereus Group

Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis

Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study

Correction to: Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study

Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma initiating daratumumab: A real-world chart review study

Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study

Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics

Systematic review of risk and protective factors associated with substance use and abuse in individuals with autism spectrum disorders

Antimicrobial Resistance in the Environment: Towards Elucidating the Roles of Bioaerosols in Transmission and Detection of Antibacterial Resistance Genes

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Real-world healthcare resource utilization and costs among patients with multiple myeloma in the United States

Comparison of Time to Next Treatment or Death between Front-Line Daratumumab, Lenalidomide, and Dexamethasone (DRd) and Bortezomib, Lenalidomide, and Dexamethasone (VRd) in Transplant Ineligible Patients with Multiple Myeloma

Ensuring a Successful Transition From Cytology to Human Papillomavirus-Based Primary Cervical Cancer Screening in Canada by Investigating the Psychosocial Correlates of Women's Intentions: Protocol for an Observational Study

Patient Characteristics, Treatment Patterns and Outcomes Among Black and White Patients with Multiple Myeloma Initiating Daratumumab: A Real-World Chart Review Study

Correction to: Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis

Treatment response among patients with multiple myeloma initiating daratumumab across different lines of therapy: A real-world chart review study

Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: The HF-ACTION study

POSTER: MM-493 Progression-Free Survival of Daratumumab vs Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients: TAURUS Chart Review Study

MM-493 Progression-Free Survival of Daratumumab vs Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients: TAURUS Chart Review Study

Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma mnitiating daratumumab: A real-world chart review study

Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials

P-115 Progression-free survival of daratumumab vs. bortezomib triplet combination with lenalidomide and dexamethasone in transplant ineligible newly diagnosed multiple myeloma patients: a chart review study

En temps de crise, prendre le temps

Ecological diversification in the Bacillus cereus Group

Suchergebnisse filtern